Breast cancer therapy involves a multidisciplinary approach comprising surgery,
radiotherapy, neoadjuvant and adjuvant therapy. Effective therapy of breast cancer requires …

Paclitaxel (PTX), the most widely used anticancer drug, is applied for the treatment of
various types of malignant diseases. Mechanisms of PTX action represent several ways in …

The task of developing CPG documents covers not only integration of the most recent
research, but also the creation of educational tools and implementation programmes for the …

Acclaimed by the worldwide medical community as" a staple reference text in the medical
oncologist's library"(JAMA), DeVita, Hellman, and Rosenberg's Cancer: Principles and …

Chemotherapy-induced neutropaenia is a major risk factor for infection-related morbidity
and mortality and also a significant dose-limiting toxicity in cancer treatment. Patients …

Chemotherapy‐induced cardiotoxicity is a serious complication that poses a serious threat
to life and limits the clinical use of various chemotherapeutic agents, particularly the …

Cytostatic antibiotics of the anthracycline class are the best known of the chemotherapeutic
agents that cause cardiotoxicity. Alkylating agents such as cyclophosphamide, ifosfamide …

Women with primary invasive breast cancer receive both local and systemic treatment.
Surgery and radiation therapy are local treatments given to reduce the risk of recurrent …

Anemia is a common complication of myelosuppressive chemotherapy that results in a
decreased functional capacity and quality of life (QOL) for cancer patients. Severe anemia is …

Cardiotoxicity, the often-overlooked second leading cause of death in cancer patients, has
been associated with certain anticancer drugs. These drugs can induce cardiac damage …